Total Payments
$2,181
2024 Payments
$26.83
Companies
20
Transactions
131
Medicare Patients
482
Medicare Billing
$38,268
Payment Breakdown by Category
Food & Beverage$2,175 (99.7%)
Education$6.96 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,175 | 130 | 99.7% |
| Education | $6.96 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $629.45 | 34 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $374.33 | 29 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $164.66 | 9 | $0 (2022) |
| Celgene Corporation | $157.50 | 10 | $0 (2022) |
| PFIZER INC. | $152.42 | 10 | $0 (2022) |
| Merck Sharp & Dohme LLC | $139.19 | 8 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $86.38 | 6 | $0 (2022) |
| INTERCEPT PHARMACEUTICALS, INC. | $60.40 | 4 | $0 (2022) |
| Ardelyx, Inc. | $56.60 | 3 | $0 (2022) |
| Ethicon US, LLC | $52.97 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.83 | 1 | Axonics, Inc. ($26.83) |
| 2023 | $22.79 | 1 | ABBVIE INC. ($22.79) |
| 2022 | $1,386 | 87 | ABBVIE INC. ($311.40) |
| 2021 | $745.84 | 42 | AbbVie Inc. ($295.26) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Urology | ||||||
| 02/27/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: VIROLOGY | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Gastroenterology | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Gastroenterology | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Gastroenterology | ||||||
| 11/21/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/07/2022 | ABBVIE INC. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Gastroenterology | ||||||
| 10/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/12/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.16 | General |
| Category: Neuroscience | ||||||
| 10/05/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Gastroenterology | ||||||
| 09/28/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.61 | General |
| 09/27/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 09/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 08/31/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/25/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Neuroscience | ||||||
| 08/24/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/17/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 354 | 358 | $98,045 | $27,773 |
| 2021 | 6 | 128 | 129 | $33,415 | $10,495 |
Total Patients
482
Total Services
487
Medicare Billing
$38,268
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $35,670 | $9,255 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $24,570 | $6,786 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 97 | $17,945 | $5,837 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 66 | $17,820 | $5,311 | 29.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $2,040 | $583.86 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $12,300 | $3,527 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 26 | $7,020 | $2,450 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 29 | $5,365 | $1,928 | 35.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $4,320 | $1,310 | 30.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $2,850 | $747.32 | 26.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,560 | $533.13 | 34.2% |
About Karen Yoder, PAC
Karen Yoder, PAC is a Nephrology healthcare provider based in Exton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982656864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karen Yoder, PAC has received a total of $2,181 in payments from pharmaceutical and medical device companies, with $26.83 received in 2024. These payments were reported across 131 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,175).
As a Medicare-enrolled provider, Yoder has provided services to 482 Medicare beneficiaries, totaling 487 services with total Medicare billing of $38,268. Data is available for 2 years (2021–2022), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Exton, PA
- Active Since 05/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1982656864
Products in Payments
- XIFAXAN (Drug) $263.98
- HUMIRA (Biological) $197.65
- ZEPOSIA (Drug) $157.50
- DIFICID (Drug) $139.19
- RINVOQ (Biological) $123.61
- XELJANZ (Drug) $122.21
- ENTYVIO (Biological) $114.31
- TRULANCE (Drug) $110.35
- MAVYRET (Drug) $105.43
- LINZESS (Drug) $94.02
- ZENPEP (Drug) $86.38
- SKYRIZI (Biological) $69.31
- OCALIVA (Drug) $60.40
- IBSRELA (Drug) $56.60
- Linzess (Drug) $47.29
- DUPIXENT (Biological) $44.72
- CREON (Drug) $39.43
- MOTEGRITY (Drug) $34.97
- INFLECTRA (Biological) $30.21
- KAPSPARGO (Drug) $28.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.